TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Glycorex Transplantation AB (publ)
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
29,962
|
36,116
|
28,202 |
Financial expenses |
386
|
247
|
402 |
Earnings before taxes |
-30,364
|
-8,520
|
-12,241 |
EBITDA |
-8,939
|
248
|
-3,349 |
Total assets |
65,844
|
96,077
|
101,799 |
Current assets |
26,137
|
45,440
|
50,557 |
Current liabilities |
14,530
|
15,822
|
13,521 |
Equity capital |
44,039
|
74,363
|
82,953 |
- share capital |
3,692
![]() |
3,692
![]() |
3,692 |
Employees (average) |
23
|
22
|
24 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
66.9%
|
77.4%
|
81.5% |
Turnover per employee |
1,303
|
1,642
|
1,175 |
Profit as a percentage of turnover |
-101.3%
|
-23.6%
|
-43.4% |
Return on assets (ROA) |
-45.5%
|
-8.6%
|
-11.6% |
Current ratio |
179.9%
|
287.2%
|
373.9% |
Return on equity (ROE) |
-68.9%
|
-11.5%
|
-14.8% |
Change turnover |
-6,154
|
7,914
|
1,202 |
Change turnover % |
-17%
|
28%
|
4% |
Chg. No. of employees |
1
|
-2
|
2 |
Chg. No. of employees % |
5%
|
-8%
|
9% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.